Both are injectable medications used to manage T2DM, but they belong to different classes 2 , 5 : -Ozempic is a brand name for the drug semaglutide, which is a GLP-1 receptor agonist that activates one hormone pathway
Lixisenatide reduces amyloid plaques, neurofibrillary tangles and neuroinflammation in an APP/PS1/tau mouse model of Alzheimers disease
If side effects are minimal, it may indicate weak receptor activation and limited efficacy
Visceral fat is metabolically active and releases inflammatory signals that influence insulin resistance and cardiovascular risk
Women considering Wegovy during perimenopause should be assessed according to standard eligibility criteria (BMI thresholds and comorbidities) rather than menopausal status alone
A maximum treatment duration of 2 years was assumed, with efficacy estimates based on an intention-to-treat analysis using the treatment-policy estimand, thereby capturing population-level effects irrespective of adherence or treatment modifications (41)